Market Tracker

09/30 9:52am ET

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

242.22
Data as of 9:37am ET
 +1.88 / +0.78%
Today’s Change
46.81
Today|||52-Week Range
497.00
+254.75%
Year-to-Date

Today’s Trading

Previous close240.34
Today’s open242.42
Day’s range240.59 - 243.89
Volume7,017
Average volume (3 months)442,637
Market cap$5.1B
Dividend yield--
Data as of 9:37am ET, 09/30/2014

Growth & Valuation

Earnings growth (last year)+48.91%
Earnings growth (this year)-252.72%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-33.71%
P/E ratioNM
Price/Sales759.12
Price/Book56.55

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-1.89-4.92%
IDXXIDEXX Laboratories I...-0.51-0.43%
UTHRUnited Therapeutics ...-2.39-1.80%
ALKSAlkermes Plc-0.61-1.39%
Data as of 9:52am ET, 09/30/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$1.09
Annual revenue (last year)$1.6M
Annual profit (last year)-$67.8M
Net profit margin-4,180.52%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts